▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #704 by analyst upside · 2026-09-20
LTGO
Latigo Biotherapeutics, Inc.
Healthcare · Market Cap $1B · P/E 0x
ANALYST PRICE TARGET
+131.7%
implied upside to consensus target
Current Price $22.55
Consensus Target $52.25
Bull Target $73.0
Bear Target $36.0
Analysts Covering 4
ANALYST CONSENSUS - BUY
Strong Buy
0
Buy
4
Hold
0
Sell
0
52-Week Low $17.22
52-Week High $25.93
YTD Return +23.6%
FUNDAMENTALS
Market Cap $1B
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-1.85
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) N/A
Profit Margin N/A
52-WEEK RANGE
52-Week Low $17.22
52-Week High $25.93
Current Price $22.55
Bear Target $36.0
Bull Target $73.0
● Now $22.55 ● Target $52.25
TRADING DATA
Avg Volume 382K
YTD Return +23.6%
Analyst Count 4
Consensus Buy
Upside to Target +131.7%
Last Updated 2026-09-20

ANALYST SUMMARY

Latigo Biotherapeutics, Inc. (LTGO) is currently trading at $22.55 with a Wall Street consensus price target of $52.25, implying potential upside of 131.7% over the next 12 months. 4 analysts currently cover LTGO, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $73.0, while the most cautious has a target of $36.0.

LTGO operates in the Healthcare sector with a market capitalisation of $1B. The stock is up 23.6% year-to-date and is currently trading near the upper end of its 52-week range of $17.22 – $25.93.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

GTBIF +119.5%
Green Thumb Industries Inc.
$2B · P/E 13.5x · Buy
MGTX +122.1%
MeiraGTx Holdings plc
$1B · P/E 15.2x · Buy
VOR +82.2%
Vor Biopharma Inc.
$1B · P/E 0.1x · Buy
OMER +84.7%
Omeros Corporation
$1B · P/E 10.8x · Hold
APMD +73.6%
Apnimed, Inc.
$1B · P/E 5.1x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for LTGO, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Leerink Partners ● Initiated
Outperform 2026-09-01 29% win rate (7 calls)
Jefferies ● Initiated
Buy 2026-09-01 50% win rate (6 calls)
Guggenheim ● Initiated
Buy 2026-09-01 62% win rate (8 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
39
out of 100
Coverage depth
12/30
Consensus clarity
0/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →